fms-Like Tyrosine Kinase 3, antagonists & inhibitors

Name
fms-Like Tyrosine Kinase 3, antagonists & inhibitors
Accession Number
DBCAT002780
Description

Not Available

Drugs
DrugDrug Description
SB-1578SB-1578 is under investigation in clinical trial NCT01235871 (A Single and Multiple-Dose Study of SB1578).
GilteritinibAn AXL receptor tyrosine kinase inhibitor used to treat relapsed or refractory acute myeloid leukemia.
Drugs & Drug Targets
DrugTargetType
GilteritinibSerum albumincarrier
GilteritinibCytochrome P450 3A4enzyme
GilteritinibReceptor-type tyrosine-protein kinase FLT3target
GilteritinibSerotonin Receptorstarget
GilteritinibP-glycoprotein 1transporter
GilteritinibMultidrug and toxin extrusion protein 1transporter
GilteritinibATP-binding cassette sub-family G member 2transporter
GilteritinibSolute carrier family 22 member 1transporter
GilteritinibTyrosine-protein kinase receptor UFOtarget
GilteritinibALK tyrosine kinase receptortarget